F

Feng Ren

Unknown

ORCID: 0000-0001-9157-9182

Publishes on Computational Drug Discovery Methods, Cancer therapeutics and mechanisms, Protein Kinase Regulation and GTPase Signaling. 109 papers and 2.9k citations.

PubIndex Score97Top 3% · mid-careerHow it's scored

109Publications

2.9kTotal Citations

First publication: 1993First senior author: 2013

Computational Drug Discovery Methods Cancer therapeutics and mechanisms Protein Kinase Regulation and GTPase Signaling Catalytic C–H Functionalization Methods Synthesis and biological activity

Top publicationsby citations

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Alex Zhavoronkov, Xiao Ding et al.|Chemical Science|2023

Cited by 322

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Feng Ren, Alex Zhavoronkov, Evgeny Izumchenko et al.|Nature Biotechnology|2024

Cited by 265

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

Yan A. Ivanenkov, Alex Zhavoronkov, Daniil Polykovskiy et al.|Journal of Chemical Information and Modeling|2023

Cited by 196

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery

Petrina Kamya, Alex Zhavoronkov, Ivan V. Ozerov et al.|Journal of Chemical Information and Modeling|2024

Cited by 125

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Frank W. Pun, Alex Zhavoronkov, Bonnie Hei Man Liu et al.|Frontiers in Aging Neuroscience|2022

Cited by 99